NO941458L - - Google Patents
Info
- Publication number
- NO941458L NO941458L NO941458A NO941458A NO941458L NO 941458 L NO941458 L NO 941458L NO 941458 A NO941458 A NO 941458A NO 941458 A NO941458 A NO 941458A NO 941458 L NO941458 L NO 941458L
- Authority
- NO
- Norway
- Prior art keywords
- burgdorferi
- polypeptide
- relates
- lyme
- disease
- Prior art date
Links
- 241000589969 Borreliella burgdorferi Species 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000016604 Lyme disease Diseases 0.000 abstract 2
- 101710159910 Movement protein Proteins 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/781,355 US5246844A (en) | 1991-10-22 | 1991-10-22 | Virulence associated proteins in borrelia burgdorferi (bb) |
| PCT/US1992/009145 WO1993008286A1 (en) | 1991-10-22 | 1992-10-21 | VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI (Bb) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941458D0 NO941458D0 (no) | 1994-04-21 |
| NO941458L true NO941458L (enrdf_load_stackoverflow) | 1994-04-21 |
Family
ID=26785129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941458A NO941458D0 (no) | 1991-10-22 | 1994-04-21 | Virulensbetingende proteiner i Borrelia Burgdorferi (Bb) |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO941458D0 (enrdf_load_stackoverflow) |
-
1994
- 1994-04-21 NO NO941458A patent/NO941458D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO941458D0 (no) | 1994-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1328286C (zh) | 无糖产物和使用方法 | |
| Darcy et al. | Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. | |
| DE69737125T3 (de) | Streptococcus pneumoniae-Antigene und Impfstoffe | |
| ATE210296T1 (de) | Immunologisches nachweisverfahren von antikörpern,die gegen gewebe-transglutaminase (ttg) gerichtet sind, verwendung von ttg zur diagnose und therapiekontrolle sowie orales pharmazeutisches mittel enthaltend ttg | |
| EP0909814A3 (en) | Use of protein kinases for the diagnosis and treatment of Alzheimer's disease | |
| DE60139690D1 (de) | Immunisierung gegen chlamydia pneumoniae | |
| EA007409B1 (ru) | Антигенные полипептиды стрептококков, способы их получения и применения | |
| WO1995014781A3 (en) | Methods for diagnosing early lyme disease | |
| RU98101249A (ru) | Омр26 антиген haemophylus influenzae | |
| MX2011000134A (es) | Vacuna contra el intermediario de plegamiento amiloide. | |
| CA2294701A1 (en) | Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease | |
| Ewing et al. | Antibody activity in ankylosing spondylitis sera to two sites on HLA B27. 1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). | |
| JPH0710774A (ja) | スプレプトコッカス・スイス感染に対するワクチン | |
| JP2003520765A (ja) | ポルフィロモナス・ジンジヴァリスによる歯周炎の治療及び予防のための保護エピトープを含有する合成ペプチド | |
| SI0998556T1 (en) | Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) | |
| NO943811L (no) | T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia | |
| PT1219301E (pt) | Vacinas contendo polipéptidos híbridos, consistindo em, pelo menos, duas proteínas alergénicas diferentes | |
| WO1992021697A3 (en) | Diagnostic peptides derived from m.tuberculosis antigens | |
| Parr et al. | Purification and measurement of secretory IgA in mouse milk | |
| WO2002081625A3 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
| NO941458L (enrdf_load_stackoverflow) | ||
| DK1261712T3 (da) | Proteiner benævnt FXTRC og nucleinsyrer kodende for samme | |
| WO2002099062A3 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
| CA2123694A1 (en) | Peptides and antibodies for treatment of rheumatoid arthritis | |
| WO2002090504A3 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |